Valuation: Solventum Corporation

Market Cap 15.04B 13.56B 12.53B 11.32B 21.42B 1,411B 21.95B 150B 59.83B 756B 56.45B 55.25B 2,405B P/E 2026 *
77.9x
P/E 2027 * 20.7x
Enterprise Value 20.02B 18.05B 16.67B 15.07B 28.51B 1,878B 29.22B 200B 79.63B 1,006B 75.14B 73.54B 3,200B EV / Sales 2026 *
2.43x
EV / Sales 2027 * 2.26x
Free-Float
81.93%
Yield 2026 *
-
Yield 2027 * -
1 day-0.41%
1 week+0.52%
Current month+7.75%
1 month+2.72%
3 months+2.74%
6 months+16.68%
Current year+10.59%
1 week 85.04
Extreme 85.045
93.1
1 month 80.76
Extreme 80.76
93.1
Current year 62.38
Extreme 62.38
94.16
1 year 62.38
Extreme 62.38
94.16
3 years 47.16
Extreme 47.16
96.05
5 years 47.16
Extreme 47.16
96.05
10 years 47.16
Extreme 47.16
96.05
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Exercice

Chief Executive Officer

160,990 0.0930%
8/17/26 A Free

Controller/Auditor

6,911 0.0040%
5/15/26 A Free

Director

3,300 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%+0.52%+18.69% - 15.04B
-0.63%-4.97%-16.20%+12.69% 189B
+0.20%-3.26%+5.86%+40.70% 124B
-0.65%-6.01%-14.27%+11.74% 121B
-0.93%-5.86%-43.65%+2.23% 93.09B
+0.18%+2.80%-3.92%+75.58% 66.77B
+0.27%-0.04%+11.11%-9.50% 58.43B
+0.50%+4.89%-1.41%+62.70% 55.35B
+0.96%-1.33%-3.37%+57.35% 49.49B
+1.75%-3.70%-5.62%-7.86% 34.53B
Average +0.14%-2.17%-5.28%+27.29% 81B
Weighted average by Cap. -0.13%-3.06%-9.78%+24.76%

Financials

2026 *2027 *
Net sales 8.25B 7.43B 6.87B 6.21B 11.75B 774B 12.04B 82.32B 32.81B 414B 30.96B 30.3B 1,319B 8.56B 7.72B 7.13B 6.44B 12.19B 803B 12.49B 85.44B 34.05B 430B 32.13B 31.45B 1,369B
Net income 200M 181M 167M 151M 285M 18.79B 292M 2B 797M 10.06B 752M 736M 32.02B 740M 667M 616M 557M 1.05B 69.41B 1.08B 7.39B 2.94B 37.17B 2.78B 2.72B 118B
Net Debt 4.98B 4.49B 4.15B 3.75B 7.09B 467B 7.27B 49.69B 19.8B 250B 18.69B 18.29B 796B 4.35B 3.92B 3.62B 3.27B 6.19B 408B 6.35B 43.39B 17.3B 218B 16.32B 15.97B 695B
Projected Income Statement - Annual - Solventum Corporation
Logo Solventum Corporation
Solventum Corporation specializes in the marketing of tools used in the medical field. Net sales break down by group of products as follows: - medical instruments and accessories (57.9%): for wound care, sterilization, surgery, etc.; - medical information systems (16.3%): primarily software solutions for documentation, billing, coding, data visualization, etc. in hospital settings; - dental and orthodontic instruments and accessories (16.2%): for dental care and restoration; - purification and filtration instruments (6%): used in the medical, bio-pharmaceutical, agri-food and other sectors; - other (3.6%). The United States accounts for 56.1% of net sales.
Employees
20,584
Date Price Change Volume
12/11/26 $87.91 -0.80% 85,309
11/11/26 $88.62 -1.62% 728,320
10/11/26 $90.08 -0.39% 1,245,269
09/11/26 $90.43 +0.06% 1,291,796
06/11/26 $90.38 +3.67% 3,168,925
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Solventum Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
88.62USD
Average target price
98.38USD
Spread / Average Target
+11.02%
  1. Stock Market
  2. Stocks
  3. SOLV Stock